Rifcin Capsule

About Rifcin 450 mg Capsule

Rifcin 450 mg Capsule is a brand of rifampicin, an anti-tubercular antibiotic used in the treatment of tuberculosis and the meningococcal carrier state. It belongs to the rifamycin group of medicines.

There are 18 brands of Rifampicin listed in Bangladesh. The lowest listed price is Firifam 150 mg Tablet at ৳ 1 per unit.

What is Rifcin 450 mg Capsule?

Rifcin 450 mg Capsule is an antibiotic made by Pharmadesh Laboratories Ltd. Its active ingredient is rifampicin, which is classed as an anti-tubercular antibiotic. It works by blocking a step that bacteria need to build RNA, which stops them from multiplying. Rifampicin is used in the treatment of tuberculosis, usually as part of a multi-drug regimen, and in the meningococcal carrier state. Because bacteria can become resistant, doctors generally prescribe it with other medicines rather than alone. The capsule is taken by mouth; the doctor decides how it fits into your treatment plan.

Uses of Rifcin

Rifcin is used in the treatment of tuberculosis, where it is normally given together with other anti-tubercular medicines as part of a combination regimen. It is also used in the meningococcal carrier state. Doctors may take samples for culture before starting therapy to confirm that the bacteria respond to rifampicin. Whether it suits a particular person depends on the diagnosis and on other medicines being taken, so the treating doctor makes that decision.

How to use Rifcin

Take the capsule by mouth with a full glass of water. Rifampicin is usually taken once daily, either about one hour before or about two hours after a meal, but your doctor will set the exact schedule. Swallow the capsule whole; if you find it hard to swallow, ask your pharmacist for advice. Do not change the timing or stop the course on your own. The doctor decides the dose and how long you take it, and any missed dose should be discussed with your doctor or pharmacist.

Side effects of Rifcin

Common effects include facial flushing and itching, with or without a rash, and flu-like symptoms such as fever, chills, headache, dizziness, bone pain and shortness of breath. Stomach upset, nausea, vomiting, loss of appetite and diarrhoea can occur. Rifampicin often turns urine, faeces, sweat, saliva, sputum and tears orange-red, which is expected. Less common problems include changes in blood counts, kidney problems and liver effects. Tell your doctor about any side effect that worries you.

Safety and precautions

Rifampicin can affect the liver, so people with liver disease need caution and medical supervision, and the doctor may arrange liver function monitoring before and during treatment. It can interact with many other medicines, including some antivirals, antacids and other drugs, so tell your doctor about everything you take. It should not be used by anyone allergic to rifampicin or other rifamycins. In the last weeks of pregnancy it can cause bleeding problems in mother and infant. Breastfeeding decisions are made with the doctor. Ask your doctor first if you are pregnant, breastfeeding, or have liver or kidney problems.

Frequently asked questions

Is Rifcin safe during pregnancy or breastfeeding?

When given in the last few weeks of pregnancy, rifampicin can cause bleeding after birth in the mother and the baby, and vitamin K treatment may be needed. For breastfeeding mothers, the decision to continue nursing or stop the medicine is made with the doctor. Tell your doctor if you are pregnant or breastfeeding before starting treatment.

What is Rifcin used for and what kind of medicine is it?

Rifcin is an anti-tubercular antibiotic. Its active ingredient, rifampicin, is used in the treatment of tuberculosis, usually alongside other anti-tubercular medicines, and in the meningococcal carrier state. It works by blocking RNA synthesis in susceptible bacteria. Your doctor will confirm whether it is suitable for your condition.

What do the dosage form and strength mean?

Rifcin comes as a capsule, which is a solid dosage form that you swallow with water. The strength is 450 mg, meaning each capsule contains 450 mg of rifampicin. The strength is information for your doctor and pharmacist; only your doctor decides the dose and course that are right for you.

Can Rifcin be taken with other medicines?

Rifampicin can change how other medicines work and can interact with many drugs, including some antivirals, antacids and other medicines processed by the liver. Always give your doctor and pharmacist a full list of everything you take, including over-the-counter products, so they can check for interactions before you start.

Indications

In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the ... Read moreIn the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampinand they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regimen should be modified.

Pharmacology

Rifampicin suppresses initiation of chain formation for RNA synthesis in susceptible bacteria by binding to the β subunit of DNA-dependent RNA polymerase, thus blocking RNA transcription.

Dosage & Administration

Rifampin can be administered by the oral route or by IV infusion. IV doses are the same as those for oral.

Tuberculosis:
  • Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
  • Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
It is recommended that oral rifampin be administered once daily, either 1 hour before or 2 hours after a meal with a full glass of water.

Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.

Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.

Interaction

May accelerate the metabolism and reduce the effect of drugs that are metabolised by CYP450 enzymes (e.g. quinidine, phenytoin, theophylline). Decreased concentrations of atovaquone and increased concentrations of rifampicin when taken concomitantly. Concurrent use of ketoconazole and rifampicin may result in decreased serum concentrations of both drugs. May decrease serum concentrations of enalaprilat. Reduced absorption by antacids. Increased risk of hepatotoxicity with halothane or isoniazid.

Contraindications

Rifampicin is contraindicated in patients with a history of hypersensitivity to rifampin or any of the components, or to any of the rifamycins. Rifampin is contraindicated in patients who are also receiving ritonavir-boosted saquinavir due to an increased risk of severe hepatocellular toxicity.

Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.

Side Effects

Facial flushing and itching, with or without a rash, flu-like syndrome characterised by episodes of fever, chills, headache, dizziness, bone pain, shortness of breath, and malaise; GI adverse effects (e.g. nausea, vomiting, anorexia, diarrhoea, epigastric distress), pseudomembranous colitis, eosinophilia, leucopenia, haemolytic anaemia; alterations in kidney function and renal failure, menstrual disturbances, oedema, myopathy, muscular weakness; orange-red discolouration of the urine, faeces, sweat, saliva, sputum, tears, and other body fluids; thrombophlebitis, local irritation and inflammation after prolonged IV infusion. Rarely, eye irritation and visual disturbances, anaphylaxis or shock.

Pregnancy & Lactation

Pregnancy: When administered during the last few weeks of pregnancy, rifampin can cause post natal hemorrhages in the mother and infant for which treatment with vitamin K may be indicated.

Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Rifampicin has been shown to produce liver dysfunction. Fatalities associated with jaundice have occurred in patients with liver disease and in patients taking rifampin with other hepatotoxic agents. Patients with impaired liver function should be given rifampin only in cases of necessity and then with caution and under strict medical supervision. In these patients, careful monitoring of liver function, especially SGPT/ALT and SGOT/AST should be carried out prior to therapy and then every 2 to 4 weeks during therapy. If signs of hepatocellular damage occur, rifampin should be withdrawn.

In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.

Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.

Overdose Effects

Nausea, vomiting, abdominal pain, pruritus, headache, and increasing lethargy will probably occur within a short time after ingestion; unconsciousness may occur when there is severe hepatic disease. Transient increases in liver enzymes and/or bilirubin may occur. Brownish-red or orange discoloration of the skin, urine, sweat, saliva, tears, and feces will occur, and its intensity is proportional to the amount ingested.

Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.

Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.

Storage Conditions

Store between 15-30° C. Avoid excessive heat and protect from light.

Alternative brands of Rifampicin

Other brands with the same generic name, cheapest first.

Firifam Tablet

150 mg

Rifampicin

Synovia Pharma PLC.

৳ 0.98 ৳ 1 2% off per unit

Firifam Tablet

450 mg

Rifampicin

Synovia Pharma PLC.

৳ 0.98 ৳ 1 2% off per unit

Rifcin Capsule

150 mg

Rifampicin

Pharmadesh Laboratories Ltd.

৳ 10.81 ৳ 11.03 2% off per unit

Rifatan Syrup

100 mg/5 ml

Rifampicin

G. A. Company Ltd.

৳ 28.8 ৳ 29.39 2% off per unit

Rifcin Syrup

100 mg/5 ml

Rifampicin

Pharmadesh Laboratories Ltd.

৳ 78.4 ৳ 80.00 2% off per unit

See all 18 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.